Transcranial Photobiomodulation in Anxiety Disorders
NCT: NCT07133893 · RECRUITING
Brief Summary
The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.
Frequently Asked Questions
What is Transcranial Photobiomodulation in Anxiety Disorders?
Transcranial Photobiomodulation in Anxiety Disorders is a clinical trial registered under NCT07133893. Current status: RECRUITING.
What is the status of NCT07133893?
The current status of NCT07133893 (Transcranial Photobiomodulation in Anxiety Disorders) is: RECRUITING.
When did Transcranial Photobiomodulation in Anxiety Disorders start?
Transcranial Photobiomodulation in Anxiety Disorders started on 2025-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.